undamentalytics Newsletter

Hasnain Faheem: insider trades

Chief executive, Director at 2 companies we cover. 7 open-market purchases and 3 sales not made under a pre-set plan, reported from August 15, 2016 to June 24, 2024.

Would copying Hasnain Faheem’s purchases have beaten the S&P 500?

Too few purchases to judge. Only 4 purchases have 12 months of prices after the report; we judge insiders once they have 20. The figures below can swing a long way on a handful of trades. Buying each purchase the day after it was reported, an equal amount each, and holding it 12 months or until they reported a sale would have turned $10,000 on August 16, 2016 into $847 by November 2, 2026, −21.5% a year. The copy held shares only 39% of the time, so the fair comparison is the S&P 500 on those same days with Treasury bills otherwise: $25,443, +9.6% a year (the S&P 500 held throughout made $40,847, +14.8% a year). Beta against the index was 0.58. Twelve months after each report, the average purchase was −48.9% against the S&P 500 (median −54.3%), and 25% beat it. Measured from the trade date, the insider’s own timing, the average was −50.8%. After their sales, the shares moved −74.3% against the index over 12 months on average (a negative figure means selling was the right call); 100% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

$0$20.0k$40.0k 201620182020202220242026 $40.8k$25.4k$847
Copying Hasnain FaheemS&P 500, same days investedS&P 500, held throughout $10,000 copying Hasnain Faheem’s open-market purchases from August 16, 2016, before costs and taxes, marked weekly. Each purchase gets the same starting stake, bought at the close of the first trading day after the report and sold 12 months later or the day after a reported sale of that stock; uninvested money earns the Treasury bill rate. “Same days invested” holds the S&P 500 only on the days the copy held shares, Treasury bills otherwise.
Return a year, copying
−21.5%
S&P 500, same days invested
+9.6% (held throughout +14.8%)
Time in shares
39%
Sharpe ratio (S&P 500)
−0.17 (0.72)
Biggest drop (S&P 500)
−96% (−34%)
Market sensitivity (beta)
0.58
Purchases copied
4

Trade by trade

Hasnain Faheem: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 4 −0.9% 0.0% 50% 4 −0.14 0.90 No reliable evidence
Purchases, 6 months after the report 4 −45.5% −34.2% 0% 4 −3.32 0.045 Some evidence: behind
Purchases, 12 months after the report 4 −48.9% −54.3% 25% 4 −1.86 0.16 No reliable evidence
Purchases, 12 months after the trade 4 −50.8% −56.9% 25% 4 −1.98 0.14 No reliable evidence
Sales, 3 months after the report 1 +2.1% +2.1% 0% 1 — — Not enough years
Sales, 12 months after the report 1 −74.3% −74.3% 100% 1 — — Not enough years
Sales, 12 months after the trade 1 −77.2% −77.2% 100% 1 — — Not enough years

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
Gossamer Bio, Inc. GOSS President & CEO52September 27, 2019June 24, 2024
Immunic, Inc. IMUX —21August 15, 2016September 17, 2018

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
June 24, 2024June 21, 2024 GOSS Purchase $249,240 not yetnot yetnot yet
March 28, 2024March 27, 2024 GOSS Sale $26,880 not yetnot yetnot yet
March 22, 2023March 20, 2023 GOSS Purchase $999,180 not yetnot yetnot yet
July 15, 2022July 15, 2022 GOSS Purchase $999,998 +13.9%−105.0%−105.4%
March 24, 2022March 23, 2022 GOSS Sale $169,792 +2.1%−74.3%−77.2%
October 14, 2020October 14, 2020 GOSS Purchase $999,947 −0.1%+18.1%+15.9%
September 27, 2019September 27, 2019 GOSS Purchase $168,000 −17.3%−37.7%−43.2%
September 17, 2018September 13, 2018 IMUX Sale $78,075 not yetnot yetnot yet
September 15, 2017September 14, 2017 IMUX Purchase $248,048 not yetnot yetnot yet
August 15, 2016August 12, 2016 IMUX Purchase $699,999 +0.1%−70.8%−70.6%

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Hasnain Faheem traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.